SMM

HOUSTEX 2023 Event Delivers Smart Manufacturing, Workforce Development Knowledge, Business Acumen to Southwest Manufacturers

Retrieved on: 
Wednesday, January 25, 2023

The two non-profits have partnered for HOUSTEX 2023 to engage industry, academia, and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.

Key Points: 
  • The two non-profits have partnered for HOUSTEX 2023 to engage industry, academia, and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.
  • HOUSTEX is part of the Manufacturing Technology (MT) Series – four regional events conducted bi-annually to share knowledge, experience, technology, and connections among manufacturers.
  • “At HOUSTEX, you will see first-hand how companies already are making ‘Smart’ changes, training their workforce, and getting great ROI.
  • Follow HOUSTEX 2023 by visiting the HOUSTEX 2023 website.

Sastanaqqam Collaborates with Boosty Labs and Reverb to Create Revolutionary Blockchain-based Ecosystem

Retrieved on: 
Thursday, February 2, 2023

This collaboration not only brings together two industry leaders, but also supports the Ukrainian blockchain ecosystem.

Key Points: 
  • This collaboration not only brings together two industry leaders, but also supports the Ukrainian blockchain ecosystem.
  • This partnership with Reverb will allow Sastanaqqam to expand its reach and gain greater visibility in the global market.
  • The collaboration with Boosty Labs, a leading Ukrainian blockchain development company, supports the Ukrainian blockchain ecosystem and promotes a peaceful resolution to the ongoing conflict in the region.
  • Reverb will also be working with Boosty Labs and Sastanaqqam to develop and implement a strong social media marketing strategy, which will help to increase its visibility and engagement with its target audience.

Kronos Bio Announces Discovery Collaboration with Genentech to Advance Novel Therapies Against Transcriptional Targets in Oncology

Retrieved on: 
Monday, January 9, 2023

SAN MATEO, Calif. and CAMBRIDGE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, announced today that it has entered into a discovery collaboration in the field of oncology with Genentech, a member of the Roche Group, focused on discovering and developing small-molecule drugs that modulate transcription factor targets selected by Genentech.

Key Points: 
  • The partnership will allow Genentech to leverage Kronos Bio’s expertise to identify protein-protein interactions, genetic dependencies and gene expression signatures to better understand and target the oncogenic activity of transcription factors in cancer types of interest.
  • Under the collaboration, researchers at the two companies will collaborate using Kronos Bio’s proprietary drug discovery platform, including the small molecule microarray (SMM) for hit finding, to build upon research conducted to date by Genentech.
  • “We are pleased to be able to leverage our unique platform to collaborate with Genentech to further Kronos Bio’s understanding of transcription-driven oncogenesis and ability to identify novel targets involved.”
    Kronos Bio will lead discovery and research activities to a defined preclinical point when Genentech will have the exclusive right to pursue further preclinical and clinical development and commercialization.
  • “We are excited about the possibilities that this collaboration with Kronos Bio brings to further our understanding of complex scientific networks with the goal of bringing highly effective medicines to patients,” said James Sabry, Global Head of Roche Pharma Partnering.

Pacific Mobile Structures Acquires Sustainable Modular Management

Retrieved on: 
Friday, December 30, 2022

CHEHALIS, Wash., Dec. 30, 2022 /PRNewswire-PRWeb/ -- Pacific Mobile Structures has acquired Sustainable Modular Management (SMM) a fellow family-owned modular building company based in Frisco, Texas. The announcement comes after Garth Haakenson, President and CEO of Pacific Mobile Structures, and Nick Mackie, President and CEO of SMM began discussing the benefits of a combined effort in the very active modular construction markets earlier this year. As a 15-year-old company, SMM is managing over 700,000 square feet of leased modular building space spanning across a diverse client base in the federal government, healthcare, education, and energy markets.

Key Points: 
  • Pacific Mobile Structures has acquired fellow family-owned modular building company, Sustainable Modular Management (SMM) located in Frisco, Texas.
  • CHEHALIS, Wash., Dec. 30, 2022 /PRNewswire-PRWeb/ -- Pacific Mobile Structures has acquired Sustainable Modular Management (SMM) a fellow family-owned modular building company based in Frisco, Texas.
  • As a Pacific Mobile-owned company, Sustainable Modular Management will continue to operate in its current form as it looks to expand its government contracting business.
  • "Pacific Mobile Structures is excited for the Sustainable Modular Management team to join our family.

AcenTek Wins the Calix Innovations “Giant of Sustainability” Award For Reducing Energy Consumption 73 Percent at the Network With Calix Intelligent Access EDGE—and Reducing Home System Energy Consumption 50 Percent With Calix Revenue EDGE

Retrieved on: 
Thursday, December 15, 2022

AcenTek leveraged energy-efficient Calix Intelligent Access EDGE and Calix Revenue EDGE platforms to deliver exceptional energy savings of 73 percent in network access edge energy consumption and 50 percent in the subscribers home network.

Key Points: 
  • AcenTek leveraged energy-efficient Calix Intelligent Access EDGE and Calix Revenue EDGE platforms to deliver exceptional energy savings of 73 percent in network access edge energy consumption and 50 percent in the subscribers home network.
  • AcenTeks pioneering green broadband strategy incorporates both the Intelligent Access EDGE and Revenue EDGE platforms to optimize energy savings.
  • As a result, AcenTek is able to:
    Reduce energy consumption by 73 percent in the network access edge.
  • Eliminating the number of network devices and the associated optical connections contributed to lowering energy consumption at the access edge by 73 percent.

Circulating Tumor Cell detection by Menarini Group's CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Retrieved on: 
Wednesday, December 14, 2022

HUNTINGDON VALLEY, Pa., Dec. 14, 2022 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the results of a study in which enumeration and genomic characterization of CTCs at varying stages of MM represents an invaluable tool to predict disease aggressiveness and pathology. This study was conducted in collaboration with Dana-Farber Cancer Institute researchers and published on December 7, 2022 in Cancer Discovery1.

Key Points: 
  • This study was conducted in collaboration with Dana-Farber Cancer Institute researchers and published on December 7, 2022 in Cancer Discovery1.
  • This type of blood cancer forms in plasma cells (PCs) located in the bone marrow (BM).
  • 1Dutta A, Alberge J-B, et al, MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology, Cancer Discov CD-22-0482.
  • * The Circulating Multiple Myeloma Cell (CMMC) test is a CLIA-accredited laboratory developed test from Menarini Silicon Biosystems in USA.

Circulating Tumor Cell detection by Menarini Group's CELLSEARCH® System leading to genomic profiling of myeloma cells shows potential for non-invasive management of Multiple Myeloma patients at early stages of disease

Retrieved on: 
Wednesday, December 14, 2022

HUNTINGDON VALLEY, Pa., Dec. 14, 2022 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the results of a study in which enumeration and genomic characterization of CTCs at varying stages of MM represents an invaluable tool to predict disease aggressiveness and pathology. This study was conducted in collaboration with Dana-Farber Cancer Institute researchers and published on December 7, 2022 in Cancer Discovery1.

Key Points: 
  • This study was conducted in collaboration with Dana-Farber Cancer Institute researchers and published on December 7, 2022 in Cancer Discovery1.
  • This type of blood cancer forms in plasma cells (PCs) located in the bone marrow (BM).
  • 1Dutta A, Alberge J-B, et al, MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology, Cancer Discov CD-22-0482.
  • * The Circulating Multiple Myeloma Cell (CMMC) test is a CLIA-accredited laboratory developed test from Menarini Silicon Biosystems in USA.

Safe-T Group: NetNut Enables its New Enterprise Cybersecurity Customers to Identify Potential Cyber Attacks

Retrieved on: 
Friday, November 25, 2022

Our solution provides cyber security companies with the ultimate tool to identify potential threats and potentially prevent future attacks.

Key Points: 
  • Our solution provides cyber security companies with the ultimate tool to identify potential threats and potentially prevent future attacks.
  • NetNut recently announced it has doubled its usage volume and processed over 36 billion customer's requests.
  • Safe-T Group Ltd. (Nasdaq: SFET) (TASE: SFET) is a global provider of cyber-security and privacy solutions to consumers and enterprises.
  • The Company operates in three distinct segments: enterprise cyber-security solutions, enterprise privacy solutions, and consumer cyber-security and privacy solutions.

Safe-T Group: NetNut Launches its New Mobile IP Proxy Network with Sales to First Three Customers

Retrieved on: 
Friday, November 18, 2022

NetNut has won its three first customers that have started using the new Mobile IP Proxy Network.

Key Points: 
  • NetNut has won its three first customers that have started using the new Mobile IP Proxy Network.
  • NetNut Ltd., a wholly owned subsidiary of Safe-T Group Ltd., is a provider of fast, reliable and scalable proxy solutions for all web scraping and web data extraction requirements.
  • By utilizing a dynamic network and delivering optimized IP pools, NetNut is the ultimate solution for scraping and collecting web data at high speed and lower rates.
  • NetNuts proxy network comprises exit points based on its proprietary reflection technology and hundreds of servers located at its ISP partners around the world.

CMTC Releases Season 7 of Modern Manufacturing Podcast “Shifting Gears”

Retrieved on: 
Thursday, November 17, 2022

California Manufacturing Technology Consulting (CMTC) announced the release of Shifting Gears Season Seven .

Key Points: 
  • California Manufacturing Technology Consulting (CMTC) announced the release of Shifting Gears Season Seven .
  • CMTC launched the Shifting Gears podcast last year to help small and medium-sized manufacturers (SMMs) keep up with emerging technologies, regulations, and industry news.
  • Last season, Shifting Gears explored government funding opportunities for manufacturers , the current state of employment and competitiveness in California manufacturing , and NIST SP 800-171 requirements .
  • Shifting Gears host, CMTC Director of Advanced Manufacturing Technologies Gregg Profozich, is joined by subject matter experts to explore each of these three topics.